A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People

PHASE1RecruitingINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

July 22, 2026

Study Completion Date

July 22, 2026

Conditions

Healthy VolunteersChronic Kidney Disease

Interventions

DRUG

NNC0705-0001

NNC0705-0001 will be administered orally.

DRUG

Placebo

Placebo matching NNC0705-0001 will be administered orally.

Trial Locations (1)

RECRUITING

ICON - location Groningen, Groningen